PineBridge Investments’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,551
Closed -$568K 497
2025
Q4
$568K Buy
9,551
+1,056
+12% +$57.5K ﹤0.01% 470
2025
Q3
$460K Sell
8,495
-26,095
-75% -$1.49M ﹤0.01% 495
2025
Q2
$1.9M Buy
34,590
+16,922
+96% +$996K 0.02% 433
2025
Q1
$1.25M Sell
17,668
-36,435
-67% -$2.45M 0.01% 464
2024
Q4
$3.56M Sell
54,103
-2,314
-4% -$155K 0.03% 378
2024
Q3
$3.97M Buy
56,417
+36,295
+180% +$3.03M 0.03% 352
2024
Q2
$1.66M Sell
20,122
-10,456
-34% -$870K 0.01% 395
2024
Q1
$2.67M Buy
30,578
+7,389
+32% +$661K 0.02% 394
2023
Q4
$2.24M Buy
23,189
+5,830
+34% +$516K 0.02% 363
2023
Q3
$1.54M Buy
+17,359
New +$1.54M 0.02% 396

Other funds holding BMRN